P-Glycoprotein and Breast Cancer Resistance Protein Affect Disposition of Tandutinib, A Tyrosine Kinase Inhibitor

By  

Drug Metabolism Letters, Vol. 4, Iss. 4, 2010-12 ,pp. : 202-212

Bentham Science Publishers

Access to resources Recommend Favorite

The 4′-O-benzylated doxorubicin analog WP744 overcomes resistance mediated by P-glycoprotein, multidrug resistance protein and breast cancer resistance protein in cell lines and acute myeloid leukemia cells

By Brooks Tracy   O’Loughlin Kieran   Minderman Hans   Bundy Brian   Ford Laurie   Vredenburg Michael   Bernacki Ralph   Priebe Waldemar   Baer Maria  

Investigational New Drugs, Vol. 25, Iss. 2, 2007-04 ,pp. : 115-122

Springer Publishing Company

Access to resources Recommend Favorite

Expression of P-glycoprotein and Multidrug Resistance-associated Protein is Associated with Multidrug Resistance in Gastric Cancer

By Xu H-W   Xu L   Hao J-H   Qin C-Y   Liu H  

The Journal of International Medical Research, Vol. 38, Iss. 1, 2010-01 ,pp. : 34-42

Field House Publishing

Access to resources Recommend Favorite

Modulation of P-glycoprotein function and multidrug resistance in cancer cells by Thai plant extracts

By  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 69, Iss. 11, 2014-11 ,pp. : 823-828

Govi-Verlag

Access to resources Recommend Favorite

P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives

By  

Current Cancer Drug Targets, Vol. 13, Iss. 3, 2013-03 ,pp. : 326-346

Bentham Science Publishers

Access to resources Recommend Favorite